Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

87.28 +0.40 (+0.46%)
Streaming Delayed Price Updated: 11:51 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices ↗
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
News headline image
Price Over Earnings Overview: Globus Medical ↗
 
Via Benzinga
News headline image
Why GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock. ↗
Delving into GLOBUS MEDICAL INC - A (NYSE:GMED)'s high Growth Prospects. 
Via Chartmill
News headline image
16 Analysts Have This To Say About Globus Medical ↗
 
Via Benzinga
News headline image
Inari Medical Stock Gets RS Rating Upgrade ↗
On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72. 
Via Investor's Business Daily
News headline image
Should you consider GLOBUS MEDICAL INC - A (NYSE:GMED) for high growth investing? ↗
Unlocking the high Growth Potential of GLOBUS MEDICAL INC - A (NYSE:GMED). 
Via Chartmill
News headline image
Novocure Stock Earns 96 RS Rating ↗
On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73. 
Via Investor's Business Daily
News headline image
Evaluating Globus Medical: Insights From 11 Financial Analysts ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Globus Medical ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts ↗
 
Via Benzinga
News headline image
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
News headline image
Globus Medical Launches ExcelsiusHub™ Navigation System
From Globus Medical
Via GlobeNewswire
News headline image
Despite its growth, NYSE:GMED remains within the realm of affordability. ↗
GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NYSE:GMED is showing good growth, while it is not too expensive. ↗
In the world of growth stocks, NYSE:GMED shines as a value proposition. 
Via Chartmill
News headline image
Looking Into Globus Medical's Recent Short Interest ↗
 
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Globus Medical Through 8 Analysts ↗
 
Via Benzinga
News headline image
CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday ↗
 
Via Benzinga
News headline image
Globus Medical (GMED) Q3 2024 Earnings Call Transcript ↗
GMED earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Globus Medical Reports Third Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
News headline image
Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions
From Globus Medical
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
While growth is established for NYSE:GMED, the stock's valuation remains reasonable. ↗
While growth is established for NYSE:GMED, the stock's valuation remains reasonable. 
Via Chartmill
News headline image
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Domino’s and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Centuri, Medpace, Customers Bancorp, and Globus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
GMED Investors Have Opportunity to Join Globus Medical, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.